Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors

Intravenous immunoglobulin prevents peripheral liver transduction of intrathecally delivered AAV vectors

Show other versions (1)

Gene therapy using neurotropic adeno-associated virus vectors represents an emerging solution for genetic disorders affecting the central nervous system. The first approved central nervous system-targeting adeno-associated virus gene therapy, Zolgensma®, for treating spinal muscular atrophy is admin...

Full description

Bibliographic Details
Main Authors: Makoto Horiuchi, Christian J. Hinderer, Jenny A. Greig, Cecilia Dyer, Elizabeth L. Buza, Peter Bell, Jessica A. Chichester, Peter M. Hayashi, Hanying Yan, Tamara Goode, James M. Wilson
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Molecular Therapy: Methods & Clinical Development
Subjects:
AAV
intrathecal
intravenous immunoglobulin
neutralizing antibodies
central nervous system
Online Access:http://www.sciencedirect.com/science/article/pii/S2329050122001425

Internet

http://www.sciencedirect.com/science/article/pii/S2329050122001425

Similar Items